The FDA recorded only 37 new drug approvals in 2022, down from an annual average of 51 since 2017. After having to retract its contentious 2021 approval of Biogen’s Aduhelm Alzheimer’s disease medication, has the FDA grown timid? The incident caused vibrations throughout the sector and even led to a government investigation of the FDA’s […]

The post FDA Drug Nods Dip To 37 In 2022 From 51- A Median Since 2017 first appeared on World Pharma Today.